G1 Therapeutics, Inc. short interest in 2022
In 2022, G1 Therapeutics, Inc.'s disclosed short interest ran from 20.95% of shares outstanding on 14 Jan 2022 to 5.98% on 30 Dec 2022, a change of -14.97 percentage points. The year's high was 20.95% on 14 Jan 2022 and its low 5.98% on 30 Dec 2022, averaging 14.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.66 days on 31 Oct 2022. Full history: G1 Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2022 in figures
- Start of year
- 20.95% (14 Jan 2022)
- End of year
- 5.98% (30 Dec 2022)
- Change
- -14.97 pp
- High
- 20.95% (14 Jan 2022)
- Low
- 5.98% (30 Dec 2022)
- Average
- 14.31%
- Highest days to cover
- 13.66 (31 Oct 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 20.95% | 11.30 | results (8-K) |
| 31 Jan 2022 | 19.86% | 8.26 | |
| 15 Feb 2022 | 19.34% | 11.54 | |
| 28 Feb 2022 | 18.75% | 9.29 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 17.69% | 11.21 | |
| 31 Mar 2022 | 14.89% | 6.36 | |
| 14 Apr 2022 | 15.04% | 10.64 | |
| 29 Apr 2022 | 15.35% | 10.56 | |
| 13 May 2022 | 14.98% | 5.70 | 10-Q filed, results (8-K) |
| 31 May 2022 | 16.97% | 6.30 | |
| 15 Jun 2022 | 18.14% | 6.55 | |
| 30 Jun 2022 | 12.21% | 2.70 | |
| 15 Jul 2022 | 11.18% | 4.77 | |
| 29 Jul 2022 | 11.10% | 5.63 | |
| 15 Aug 2022 | 8.79% | 2.30 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 8.10% | 5.89 | |
| 15 Sep 2022 | 9.06% | 3.96 | |
| 30 Sep 2022 | 15.02% | 4.95 | |
| 14 Oct 2022 | 16.46% | 11.08 | |
| 31 Oct 2022 | 17.55% | 13.66 | |
| 15 Nov 2022 | 14.35% | 4.76 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 10.50% | 2.30 | |
| 15 Dec 2022 | 11.11% | 4.12 | |
| 30 Dec 2022 | 5.98% | 2.73 |
See also: G1 Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.